Wednesday, June 11, 2014

The Motley Fool: Is Medtronic a Buy? What Analyst Day Revealed

Medtronic's (NYSE: MDT  ) June 6 analyst day was by no means light fare, as the company crammed quite a bit of information into more than seven hours. While action-oriented investors are likely disappointed that management's commentary would seem to suggest a bid for Smith & Nephew (NYSE: SNN  ) is not too likely, management laid out a vision of an evolving global device market where Medtronic is likely to be among the few players with the scale to really cover all of the major bases. While Medtronic shares do not appear priced for supreme near-term market outperformance, they still make sense within a diversified portfolio that tends toward the conservative.

Continue here:
Is Medtronic a Buy? What Analyst Day Revealed

No comments: